Products
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 26A033 | TRI-611 | 3117940-39-0 | ≧98.0% |  |
| TRI-611 is an Oral ALK Molecular Glue Degrader. | ||||
| 26A034 | CID-078 | 3064485-16-8 | ≧98.0% |  |
| CID-078 is a novel, orally bioavailable, passively cell-permeable, potent and selecti | ||||
| 26A035 | AMX-883 | ≧98.0% |  | |
| Amx-883 is a potent and selective degrader of BRD9 drives differentiation in acute my | ||||
| 26A036 | Nomelcitinib ( D-2570 ) | 2794195-73-4 | ≧98.0% |  |
| Nomelcitinib (D-2570) is a novel TYK2 allosteric inhibitor. | ||||
| 26A037 | Abdenoflast | 2712741-60-9 | ≧98.0% |  |
| Abdenoflast (VTX2735) is a small-molecule, non-steroidal inhibitor of the NLRP3 infla | ||||
| 26A038 | Pantothenate kinase-IN-2 | 902614-04-4 | ≧98.0% |  |
| Pantothenate kinase-IN-2 is a pantothenate kinase inhibitor with IC50 values of 92 nM | ||||
| 26A039 | PZ-3022 | 2170608-85-0 | ≧98.0% |  |
| PZ-3022 is an allosteric PanK activator that counteracts C3-CoA inhibition. | ||||
| 26A040 | Claziprotamidum ( Claziprotamide ; BBP-671 ) | 2361124-03-8 | ≧98.0% |  |
| Claziprotamidum ( Claziprotamide ; BBP-671 ) is a potent, orally active, and blood-br | ||||
| 26A041 | Pantothenate kinase-IN-3 (also known as Compound 21) | ≧98.0% |  | |
| Pantothenate kinase-IN-3 (also known as Compound 21,https://doi.org/10.1021/acs.jmedc | ||||
| 26A042 | Mitoquinol mesylate (MitoQ) | 845959-55-9 | ≧96.0% |  |
| Mitoquinol mesylate (MitoQ) is a mitochondria-targeted antioxidant, specifically a sy | ||||
| 26A043 | BI 44370 | 866086-05-7 | ≧98.0% |  |
| BI 44370 was developed as a calcitonin gene-related peptide(CGRP)receptor antagonist | ||||
| 26A044 | Gridegalutamide | 2446929-86-6 | ≧98.0% |  |
| gridegalutamide is an orally bioavailable androgen receptor (AR) degrader, with poten | ||||